ENTITY
Laurus Labs

Laurus Labs (LAURUS IN)

65
Analysis
Health Care • India
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .
more
bullish•Laurus Labs
•11 Aug 2018 20:21

Laurus Labs - 1QFY19- One More Difficult Quarter Ahead, Strong Growth in FY20E

Laurus Labs reported 1QFY19 results on 3rd August 2018 and held a conference call on 4th August 2018. Revenues grew 9.7% YoY to Rs. 5,390 Mn,...

Share
bullish•Laurus Labs
•22 Jun 2018 20:06

Laurus Labs - Annual Report Review

According to Annual Report FY18, Laurus Labs (LAURUS IN) has strengthened its business with strong R&D, building capacities and expanding...

Share
bullish•Laurus Labs
•14 May 2018 20:29

Laurus Labs- 4QFY18 Result Update

Laurus Labs reported 4QFY18 results on 10th May 2018 and held a conference call on 11th May 2018.Performance Highlights  Laurus reported Q4FY18...

Share
bullish•Laurus Labs
•10 Mar 2018 15:19

Laurus Labs- Moving up the Value Addition Ladder

Laurus Labs (LAURUS IN) is a research and development driven pharmaceutical company. It is a manufacturer of APIs for ARV, Hepatitis C, oncology...

Share
bullish•Smartkarma
•24 Dec 2016 12:21

Smartkarma - ECM Coverage Weekly Update (26 Dec 2016)

Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs.Accuracy Rate:Our accuracy...

Share
x